Abstract
We report three cases of pathological gambling induced by Aripiprazole, in patients with schizophrenia or schizoaffective disorder. All three patients had no history of pathological gambling, and they started gambling after initiation of treatment with Aripiprazole. The fact that pathological behavior disappeared quickly as medication ends suggests that an elaborate behavioral manifestation could be related to dopaminergic tone in patients with schizophrenia. We recommend consideration with increased attention for the appearance of pathological gambling symptoms among patients on Aripiprazole.
Keywords: Pathological gambling, schizophrenia, schizoaffective disorder, dopamine agonist, behavioral addiction, dopamine D3 receptor, Aripiprazole, PG, DSM -IV, ICD, SOGS, MINI, Gender (M/F), Age, bipolar disorder., Hypersexuality, MCL, Amilsupride, Risperidone, Haldol, compulsive eating, stimulation, dopaminergic
Current Drug Safety
Title: Aripiprazole-Induced Pathological Gambling: A Report of 3 Cases
Volume: 6 Issue: 1
Author(s): Julien Cohen, David Magalon, Laurent Boyer, Nicolas Simon and Christophe Lancon
Affiliation:
Keywords: Pathological gambling, schizophrenia, schizoaffective disorder, dopamine agonist, behavioral addiction, dopamine D3 receptor, Aripiprazole, PG, DSM -IV, ICD, SOGS, MINI, Gender (M/F), Age, bipolar disorder., Hypersexuality, MCL, Amilsupride, Risperidone, Haldol, compulsive eating, stimulation, dopaminergic
Abstract: We report three cases of pathological gambling induced by Aripiprazole, in patients with schizophrenia or schizoaffective disorder. All three patients had no history of pathological gambling, and they started gambling after initiation of treatment with Aripiprazole. The fact that pathological behavior disappeared quickly as medication ends suggests that an elaborate behavioral manifestation could be related to dopaminergic tone in patients with schizophrenia. We recommend consideration with increased attention for the appearance of pathological gambling symptoms among patients on Aripiprazole.
Export Options
About this article
Cite this article as:
Cohen Julien, Magalon David, Boyer Laurent, Simon Nicolas and Lancon Christophe, Aripiprazole-Induced Pathological Gambling: A Report of 3 Cases, Current Drug Safety 2011; 6 (1) . https://dx.doi.org/10.2174/157488611794480016
DOI https://dx.doi.org/10.2174/157488611794480016 |
Print ISSN 1574-8863 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3911 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Predicting Drug Metabolism Induction In Silico
Current Topics in Medicinal Chemistry Metabolic Profiling in Multiple Sclerosis and Other Disorders by Quantitative Analysis of Cerebrospinal Fluid Using Nuclear Magnetic Resonance Spectroscopy
Current Pharmaceutical Biotechnology Temporal Progression of Kainic Acid Induced Changes in Vascular Laminin Expression in Rat Brain with Neuronal and Glial Correlates
Current Neurovascular Research Histone Deacetylase (HDAC) Inhibitors - emerging roles in neuronal memory, learning, synaptic plasticity and neural regeneration
Current Neuropharmacology Insulin and the Brain
Current Diabetes Reviews Genetically Modified Mice Models for Alzheimers Disease
Current Topics in Medicinal Chemistry Natural Sourced Inhibitors of EGFR, PDGFR, FGFR and VEGFRMediated Signaling Pathways as Potential Anticancer Agents
Current Medicinal Chemistry Motor Recovery after Chronic Spinal Cord Transection in Rats: A Proof-of-Concept Study Evaluating a Combined Strategy
CNS & Neurological Disorders - Drug Targets Anionic Linear Globular Dendrimer-G2-Ciprofloxacin Nano-Conjugate: Novel Agent against Wilson Disease Cell Model
Letters in Drug Design & Discovery Th17 and Treg Cells, Two New Lymphocyte Subpopulations with a Key Role in the Immune Response Against Infection
Infectious Disorders - Drug Targets Microglia and Neuropathic Pain
CNS & Neurological Disorders - Drug Targets Comparing the Molecular Pharmacology of CGRP and Adrenomedullin
Current Protein & Peptide Science Renin-Angiotensin-Aldosterone System: A Current Drug Target for the Management of Neuropathic Pain
Current Drug Targets Plant Secondary Metabolites in Cancer Chemotherapy: Where are We?
Current Pharmaceutical Biotechnology Sialuria-Related Intellectual Disability in Children and Adolescent of Pakistan: Tenth Patient Described has a Novel Mutation in the GNE Gene
CNS & Neurological Disorders - Drug Targets Serum Albumin Concentration and Cognitive Impairment
Current Alzheimer Research Erratum
CNS & Neurological Disorders - Drug Targets Screening of Early and Late Onset Alzheimer’s Disease Genetic Risk Factors in a Cohort of Dementia Patients from Liguria, Italy
Current Alzheimer Research Screening of Some Novel 4, 5 Disubstituted 1, 2, 4-Triazole-3-thiones for Anticonvulsant Activity
Central Nervous System Agents in Medicinal Chemistry Methylene Blue Inhibits the Function of α7-Nicotinic Acetylcholine Receptors
CNS & Neurological Disorders - Drug Targets